Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer

Clinical trial NCT03015740 · COMPLETED

Trial details

NCT number: NCT03015740
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic Kidney Carcinoma Stage III Renal Cell Cancer AJCC v7 Stage IV Renal Cell Cancer AJCC v7

Start date: 2017-04-23
Primary completion: 2022-09-06
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.